A Certificate of Analysis is the document that converts a vial of research peptide from “trust the label” into “trust the data.” It’s the difference between a sample you can publish about and a sample whose identity you can’t verify. Despite that importance, the document itself is intimidating the first time you see one — a wall of chromatograms, retention times, m/z ratios, and lab abbreviations.

This guide walks the major sections of a research-peptide COA in plain language, explains what each measurement actually demonstrates, and flags the patterns that distinguish a real COA from a manufactured-on-Photoshop one. Everything is research-frame methodology language. No protocol guidance. No clinical claims.

Research use only

This guide is for laboratory researchers verifying the identity and purity of research-grade peptide samples. It is not a substitute for in-house QC, not a clinical document, and not a basis for therapeutic decisions of any kind.

The five sections every COA must have

Every legitimate research-peptide COA includes five categories of information. Anything missing on this list is a red flag:

  1. Sample identification — compound name, lot/batch number, manufacturing date, analysis date
  2. Identity confirmation — usually mass-spectrometry (MS) molecular weight verification
  3. Purity quantification — HPLC chromatogram with peak area % at the target retention time
  4. Physical characterization — appearance, water content, solubility
  5. Lab attribution — testing facility name, analyst signature, date stamp

A COA missing the lot number, analysis date, or testing-facility attribution is not a COA — it’s a marketing graphic. Treat it as such.

HPLC chromatogram — the purity proof

HPLC (High-Performance Liquid Chromatography) separates a sample into its constituent peaks based on how each molecular species interacts with the stationary phase. For a single-compound research peptide, you expect one dominant peak representing the target molecule, and ideally nothing else.

Reading the chromatogram

The X-axis is retention time (minutes); the Y-axis is signal intensity (mAU — milli-absorbance units). The peak’s area, integrated against total chromatogram area, gives the purity percentage. Research-grade peptide COAs typically report this as “Peak Area %” and target ≥98%.

What to look for on the HPLC trace:

  • One tall, sharp peak at the expected retention time for that peptide. Sharp = compound integrity. Broad = aggregation or degradation.
  • Minimal small peaks elsewhere on the trace. These are impurities — synthesis byproducts, oxidation products, deletion sequences. The smaller and fewer they are, the higher the purity.
  • Reported “Peak Area %” at the target retention time. Target: ≥98.0% for research-grade. Anything below 95% is a quality issue.
  • Method parameters listed — column type (e.g., C18 reversed-phase), mobile phase (e.g., 0.1% TFA in water/acetonitrile), gradient, flow rate, wavelength (typically 220 nm for peptide bonds, sometimes 280 nm for aromatic residues). A real HPLC method will be documented.

Mass spectrometry (MS) — the identity proof

HPLC tells you “this peak is mostly one thing.” Mass spectrometry tells you which thing. The MS report on a COA confirms that the dominant HPLC peak has the molecular weight expected for the target peptide.

Three numbers matter on an MS report:

  • Theoretical (calculated) mass — derived from the peptide’s amino-acid sequence. This is fixed; you can recompute it.
  • Observed mass — what the mass spectrometer actually measured for the dominant peak.
  • Mass accuracy — the difference between theoretical and observed, usually expressed in Daltons or ppm. Research-grade peptide MS analysis should match within ±0.5 Da for low-resolution and well below 10 ppm for high-resolution instruments.

If the COA says “Theoretical: 4113.58 / Observed: 4113.4” for Semaglutide, that’s identity-confirmed. If the observed mass differs by tens of daltons, something is wrong — wrong sample, wrong synthesis, or wrong COA.

Water content — why it changes how much peptide you actually have

Lyophilized peptides contain residual water from the freeze-drying process, plus counterion mass (TFA salt or acetate, depending on synthesis cleanup). A 5 mg vial is not 5 mg of bare peptide — it’s 5 mg of peptide-plus-water-plus-counterion.

Research-grade COAs typically report:

  • Water content (Karl Fischer titration): typically 1–8%, depending on peptide length and lyophilization conditions. Higher water means more re-dissolution but less actual peptide per labeled mg.
  • Counterion type and approximate content: TFA salt is common after RP-HPLC purification. Mass adjustments are documented if explicit “net peptide content” is reported.
  • Net peptide content — the most useful number when present. Backs out water and counterion to give the actual peptide mass.

Endotoxin testing — what it is and isn’t

Endotoxin (lipopolysaccharide, LPS) is bacterial cell-wall debris that contaminates peptide preparations if synthesis or handling is not clean. Endotoxin testing — typically by Limulus Amebocyte Lysate (LAL) assay — quantifies this contamination.

For research-grade peptides intended for in-vitro work, endotoxin levels matter because LPS is biologically active in many model systems and can confound research outcomes (especially in immune, inflammation and cellular assays). Research-grade COAs that include endotoxin testing typically report:

  • Endotoxin level in EU/mg (Endotoxin Units per milligram of peptide)
  • Method: LAL gel-clot, LAL turbidimetric, or chromogenic LAL

For peptides used in in-vitro research only, low-endotoxin grades are not always required, but for in-vivo research-model work or sensitive cell assays, endotoxin testing should be on the COA.

Lot number, dates, and traceability

Every research-grade peptide vial belongs to a specific synthesis lot. The lot number ties the vial in your hand back to the original synthesis batch, the QC analysis on that batch, and any retained reference samples. Without lot traceability, the COA is detached from the product.

What to verify:

  • Lot/batch number on the COA matches the lot/batch number on the vial label. Mismatched lot numbers mean the COA is for a different batch.
  • Manufacture date — when the synthesis was completed
  • Analysis date — when the QC tests in this COA were performed (should be on or after manufacture date)
  • Expiry / re-test date — when the lot needs re-analysis (typically 24 months for properly stored lyophilized peptides)

Red flags — patterns that indicate a fake or cargo-cult COA

Verification checklist

The patterns below are how legitimate COAs differ from manufactured-on-demand graphics. Some unscrupulous suppliers issue identical-looking COAs across all their batches because the document is for marketing rather than QC.

  • Identical chromatograms across multiple lots. Each synthesis batch produces a different chromatogram trace — peak shapes, retention times shift slightly, baseline noise differs. Two lots with byte-identical chromatogram images is statistically impossible from real HPLC equipment.
  • Round-number purity claims with no decimal places — “99% pure” with no chromatogram is meaningless. Real HPLC reports “98.7%” or “99.3%” — actual integrated peak area percentages.
  • Missing or generic lot number — “Lot 001” across an entire catalog is suspicious.
  • No testing-facility attribution — “Tested” without a lab name, address, or analyst signature.
  • No dates — without manufacture and analysis dates, the COA is detached from time.
  • Cited methods that don’t match the data shown — claiming “HPLC ≥98%” but showing only a mass-spectrum, or vice versa.
  • Cosmetic logos and stock photos instead of actual chromatogram images. Real COAs are technical documents; they look like lab reports, not marketing flyers.

How TogoPeptide COAs are structured

Every TogoPeptide research-peptide shipment includes a per-batch Certificate of Analysis covering:

  • Compound name, CAS number, lot number, manufacture date, analysis date, expiry
  • HPLC chromatogram with target ≥98% peak area at the expected retention time
  • Mass-spectrometry molecular-weight confirmation against theoretical
  • Appearance, solubility, water content (Karl Fischer)
  • Testing facility attribution + analyst signature

Each lot’s COA is unique — derived from that batch’s actual analytical run, not a stock template. For multi-batch research designs where lot consistency matters, request matching lot numbers at order time.

Browse public per-batch COAs in our COA library for representative examples across the catalog.

Closing — methodology, not certification

A Certificate of Analysis is methodology documentation: it tells you what was measured, how it was measured, and what was found. It is not a regulatory certification, not a clinical authorization, and not a guarantee of fitness for any application beyond the laboratory research framing.

For research-supply or methodology questions, contact our research-supply team at info@togopeptide.com. For full per-batch COAs of compounds you’ve ordered, request the lot-specific PDF — every order includes one.

Related research-handling references:

References

  1. USP <1056> Biotechnology-Derived Articles — Polyacrylamide Gel Electrophoresis. United States Pharmacopeia. Methods reference.
  2. USP <921> Water Determination — Karl Fischer titration methodology. United States Pharmacopeia. Methods reference.
  3. Eurofins Genomics. Peptide synthesis QC methodology overview. Industry methodology reference.
  4. Snyder LR, Kirkland JJ, Dolan JW. Introduction to Modern Liquid Chromatography. Wiley, 3rd edition. Standard reference for HPLC methodology.
  5. Hancock WS, Sparrow JT. HPLC analysis of biologically-active peptides. J Chromatogr. 1981. PubMedPMID: 7298567
  6. USP <85> Bacterial Endotoxins Test — LAL methodology. United States Pharmacopeia. Methods reference.